Ubs Group Ag Assertio Holdings, Inc. Transaction History
Ubs Group Ag
- $555 Billion
- Q2 2025
A detailed history of Ubs Group Ag transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 334,210 shares of ASRT stock, worth $280,736. This represents 0.0% of its overall portfolio holdings.
Number of Shares
334,210
Previous 212,673
57.15%
Holding current value
$280,736
Previous $142,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding ASRT
# of Institutions
85Shares Held
26.6MCall Options Held
449KPut Options Held
60K-
Nantahala Capital Management, LLC New Canaan, CT8.81MShares$7.4 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.38MShares$3.68 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.82MShares$2.37 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.39MShares$1.16 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.02MShares$857,9610.0% of portfolio
About Assertio Holdings, Inc.
- Ticker ASRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 48,178,200
- Market Cap $40.5M
- Description
- Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...